Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. GlycoMimetics, Inc. acquired by Crescent BioPharma in an Reverse Merger, where GlycoMimetics changed its name to Crescent BioPharma, Inc.
Echo360 combines all of the video capabilities into a single, smart solution that is so easy to manage. It aims to transform teaching and learning through active learning technology. Echo360 was formed as a subsidiary of Anystream, the world leader in digital media production and workflow management solutions for major media companies. Drawing on a proven track record and history as a technology innovator combined with a clear vision of how technology could better serve education institutions and students around the world, Echo360 has emerged as the global leader in active learning technology. It was founded in 2007 and is headquartered in Dulles, Virginia.
Siperian helps companies unify critical data about customers, products and organizations that is fragmented across systems to deliver reliable, complete views of this data within existing business processes. With unified views of key business entity data, companies can benefit from information assets within operating and analytical business processes. Siperian MDM Hub™ offers the next generation of architectural flexibility for managing all master data with an integrated, model-driven software platform that adapts to your business requirements-- and delivers rapid return on investment in critical MDM projects today while evolving to a complete enterprise MDM platform. Siperian's approach enables rapid implementation and has earned the company its reputation for leadership and proven success. Siperian solutions meet the complex requirements of market-leading companies in financial services, health and life sciences, manufacturing and technology, information services and media and other industry sectors improve customer relationship management and analytical processes, along with regulatory compliance, order-to-cash and new product launch processes—at faster time-to-value and higher return on investment compared to alternatives. The company markets and supports its leading MDM solutions through its own sales, professional services and support organizations in concert with its partner program network of systems integrators and technology providers. Their partners include, among others, Accenture, HP, CSC, BearingPoint, IBM, Identity Systems, Salesforce.com, Harte Hanks Trillium Software, Business Objects, Cognos and Experian. Pfizer, Deutsche Bank, Forest Laboratories, Allergan, State Street Bank, EcoLab, EMC Corporation and LexisNexis are among the Fortune 500 companies that trust Siperian solutions. With proven deployments, these satisfied customers operate large-scale master data management solutions addressing customer, location and product data to support both analytical and transactional business needs.
Redlasso is a web service that allows users to search TV and radio broadcasts, create clips and share them. On May 20, 2008, it was leaked that RedLasso had been [served](http://www.techcrunch.com/2008/05/20/bloggers-rejoice-customized-tv-clips-with-redlasso/) a Cease and Desist letter from a number of major media organizations. In response, the company [brought on](http://corp.redlasso.com/press/Redlasso-052908-01.pdf) Michael Jordan, former CEO of CBS and Westinghouse Corporation, as a senior advisor.
Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnecting through cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. GlycoMimetics, Inc. acquired by Crescent BioPharma in an Reverse Merger, where GlycoMimetics changed its name to Crescent BioPharma, Inc.
Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, call centers, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland.
Triumfant provides continuous protection from advanced malware threats on the endpoint, stopping cybercriminals in their tracks. Offering the most advanced detection capabilities and featuring enhanced memory and Mac features, Triumfant ensures that once inside a company’s or government agency’s systems, no attacker can leave with proprietary information, damage to enterprise systems is minimized, and critical assets are secured. Triumfant stops a breach before it becomes a full-scale attack then automatically repairs the machine(s) and any collateral damage within minutes – no human intervention or system downtime is required. When attacks occur, companies and government entities trust Triumfant to quickly recover and prevent loss.
Immune Control, Inc. was formed in 2001 based on technology developed in the laboratories of Professors Bradford Jameson and Ana Tretiakova, Department of Biochemistry, Drexel University College of Medicine. Initial funding came from Argil Management, LLC, of Boston. In 2003, Stephen Roth, Ph.D., became president and CEO of Immune Control. The Company plans to complete an investigational new drug (IND) application to be submitted to the Food and Drug Agency in 2005. The IND application will propose the use of an already marketed serotonin antagonist in multiple myeloma patients in a small, and relatively short, phase 1/2 clinical trial. If the drug has significant, clinical efficacy against the malignant B cells characteristic of multiple myeloma, they would immediately begin plans for a larger, phase 3 trial. Positive results in the first trial would constitute clinical proof-of-concept for the Company's basic premise-that serotonin antagonists have clinical utility against inappropriately activated immune cells. Another Company goal focuses on proprietary serotonin antagonists that are more potent than those already approved, and that do not cross the blood-brain barrier, making them free of adverse neurological side-effects. Such new chemical entities would be screened for their abilities to bind to specific immunological serotonin receptors, which are now being characterized. The Company has made progress with at least two receptors, one of which has apparently not previously been described. Research on the molecular biology of the receptors is underway at Drexel University College of Medicine, and new chemical entities to be screened for serotonin antagonist activity are being synthesized for the Company. Ultimately, they hope to find compounds that can be used against many hematologic cancers, transplant rejection, and against a host of diseases that are all caused by inappropriate lymphocyte activation. Examples of such diseases are type I diabetes, rheumatoid arthritis, lupus, asthma, and many of the muscular dystrophies. The market size for drugs that treat each of these conditions exceeds a billion dollars. Simultaneously, the Company aggressively protects its intellectual property with patent applications. Novel use applications, novel compound applications, and novel receptor applications are all examples of the Company's existing IP portfolio, which has been licensed exclusively and worldwide to the Company by Drexel University.
Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnecting through cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. GlycoMimetics, Inc. acquired by Crescent BioPharma in an Reverse Merger, where GlycoMimetics changed its name to Crescent BioPharma, Inc.
Nucleonics
Series B in 2004
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, call centers, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland.
BioRexis has developed proprietary protein engineering technologies based upon human transferrin that provide novel therapeutic agents with longer duration of action than synthetic peptides. In addition to reducing dosing frequency, these technologies have the potential to substantially improve patient tolerability. This new platform supports Pfizer’s commitment to develop novel protein therapeutic agents.
Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, call centers, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland.
Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnecting through cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. GlycoMimetics, Inc. acquired by Crescent BioPharma in an Reverse Merger, where GlycoMimetics changed its name to Crescent BioPharma, Inc.
Siperian helps companies unify critical data about customers, products and organizations that is fragmented across systems to deliver reliable, complete views of this data within existing business processes. With unified views of key business entity data, companies can benefit from information assets within operating and analytical business processes. Siperian MDM Hub™ offers the next generation of architectural flexibility for managing all master data with an integrated, model-driven software platform that adapts to your business requirements-- and delivers rapid return on investment in critical MDM projects today while evolving to a complete enterprise MDM platform. Siperian's approach enables rapid implementation and has earned the company its reputation for leadership and proven success. Siperian solutions meet the complex requirements of market-leading companies in financial services, health and life sciences, manufacturing and technology, information services and media and other industry sectors improve customer relationship management and analytical processes, along with regulatory compliance, order-to-cash and new product launch processes—at faster time-to-value and higher return on investment compared to alternatives. The company markets and supports its leading MDM solutions through its own sales, professional services and support organizations in concert with its partner program network of systems integrators and technology providers. Their partners include, among others, Accenture, HP, CSC, BearingPoint, IBM, Identity Systems, Salesforce.com, Harte Hanks Trillium Software, Business Objects, Cognos and Experian. Pfizer, Deutsche Bank, Forest Laboratories, Allergan, State Street Bank, EcoLab, EMC Corporation and LexisNexis are among the Fortune 500 companies that trust Siperian solutions. With proven deployments, these satisfied customers operate large-scale master data management solutions addressing customer, location and product data to support both analytical and transactional business needs.
ScoreBoard, Inc. offers innovative software and services designed to assist wireless telecommunications carriers in optimizing their network performance. By collecting and analyzing measured network data, the company enables carriers to explore various scenarios related to network reliability and capacity. This solution addresses the challenges faced by mobile operators, such as resource scarcity and heightened consumer expectations, particularly in a challenging financial environment. Through its offerings, ScoreBoard aims to help carriers better meet their commitments to investors and customers alike.
Highway to Health, (HTH) applies its dynamic Internet expertise to bring innovative online healthcare services and insurance to international travel, study, and commerce. Each year thousands of leisure and business travelers as well as international students and scholars protect themselves, their families, and their travel plans with HTH. Their programs combine comprehensive, competitively priced insurance products with critical travel health information, known as CityHealthProfiles, and online medical assistance services available through HTH TravelersClub. Members enjoy access to their community of pre-selected, contracted physicians in over 100 countries, and their interactive translation guides for brand-name pharmaceuticals and common medical terms and phrases.
ScoreBoard, Inc. offers innovative software and services designed to assist wireless telecommunications carriers in optimizing their network performance. By collecting and analyzing measured network data, the company enables carriers to explore various scenarios related to network reliability and capacity. This solution addresses the challenges faced by mobile operators, such as resource scarcity and heightened consumer expectations, particularly in a challenging financial environment. Through its offerings, ScoreBoard aims to help carriers better meet their commitments to investors and customers alike.
Message Pharmaceuticals is a company that provides Communications systems and more.